Victoza

Before taking this medicine

Do not use Victoza if you or anyone in your family has had medullary thyroid carcinoma (MTC), if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you have had a serious allergic reaction to liraglutide or any ingredient in Victoza. Victoza is not recommended for people with severe gastroparesis (severely delayed stomach emptying). During pregnancy, it should be used only if the potential benefit justifies the potential risk to the fetus. Important precautions include: • Pancreatitis: stop using Victoza if pancreatitis is suspected. • Serious allergic reactions, including anaphylaxis and angioedema: stop using Victoza and promptly seek medical advice if a reaction occurs. • Low blood sugar: the risk, including severe episodes, is increased in adults using insulin or medicines that stimulate insulin release. Children aged 10 years and older have an increased risk regardless of insulin or metformin use. • Severe gastrointestinal reactions and dehydration: reactions that cause fluid loss can lead to acute kidney injury. Kidney function should be monitored if these occur. • Gallbladder disease: suspected gallstones or gallbladder inflammation require investigation. • Surgery or procedures: tell your healthcare team about any planned procedure involving general anesthesia or deep sedation. Aspiration, where stomach contents enter the lungs, has been reported with this class of medicines. Never share a Victoza pen with another person, even if the needle is changed.